NCT06286657

Xanthohumol and Viral Infections (XL)

Xanthohumol in the Prevention of Virus-mediated Upper Respiratory Tract Infections in Humans

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: University of Vienna · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.

Detailed description

In this placebo-controlled study, blood is taken on the first day of the study, followed by a 90-day intervention with xanthohumol or a placebo, which is taken twice daily. Blood samples will be taken on day 0, day 45 and day 90. Should the study participants develop a respiratory infection during the study, they will be asked to perform a self-test.

Conditions

• Infection Viral

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Xanthohumol	Participants consume twice per day a study drink which contains 0,75 mg soluble Xanthohumol for 90 days
DIETARY_SUPPLEMENT	Placebo	Participants consume twice per day a study drink which contains 0 mg soluble Xanthohumol for 90 days

Timeline

• Start date: 2023-08-01
• Primary completion: 2025-10-31
• Completion: 2025-12-30
• First posted: 2024-02-29
• Last updated: 2025-04-15

Locations

1 site across 1 country: Austria